Standard BioTools Inc. Increase (Decrease) in Deferred Revenue
Standard BioTools Inc. (LAB) reported Increase (Decrease) in Deferred Revenue of $368.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-08
- Standard BioTools Inc. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$352.00K.
- Standard BioTools Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $720.00K, a 9.09% decline year-over-year.
- Standard BioTools Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $728.00K.
- Standard BioTools Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $1.32M, a 1237.37% increase year-over-year.
- Standard BioTools Inc. increase (decrease) in deferred revenue for fiscal 2017 was $1.64M.
- Standard BioTools Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$274.00K, a 110.49% decline from fiscal 2015.
- Standard BioTools Inc. increase (decrease) in deferred revenue for fiscal 2015 was $2.61M, a 18.11% decline from fiscal 2014.
- Standard BioTools Inc. increase (decrease) in deferred revenue for fiscal 2014 was $3.19M, a 94.57% increase from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2018-06-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $368.00K 10-Q · filed 2018-08-08 | $1.10M derived: sum of 3 quarters · filed 2018-08-08 | $2.42M derived: sum of 4 quarters · filed 2018-08-08 | |
| 2018-03-31 | $720.00K 10-Q · filed 2018-05-08 | $1.45M derived: sum of 2 quarters · filed 2018-05-08 | $2.77M derived: sum of 3 quarters · filed 2018-05-08 | $1.56M derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-12-31 | $728.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.05M derived: sum of 2 quarters · filed 2018-03-08 | $844.00K derived: sum of 3 quarters · filed 2018-08-08 | $1.64M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $116.00K derived: sum of 2 quarters · filed 2018-08-08 | $908.00K 10-Q · filed 2017-11-07 | $119.00K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$416.00K 10-Q · filed 2018-08-08 | -$1.21M derived: sum of 3 quarters · filed 2018-08-08 | -$1.11M derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $792.00K 10-Q · filed 2018-05-08 | $3.00K derived: sum of 2 quarters · filed 2018-05-08 | $102.00K derived: sum of 3 quarters · filed 2018-05-08 | $13.00K derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | -$789.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$690.00K derived: sum of 2 quarters · filed 2018-03-08 | -$779.00K derived: sum of 3 quarters · filed 2018-03-08 | -$274.00K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $10.00K derived: sum of 2 quarters · filed 2017-11-07 | $515.00K 10-Q · filed 2017-11-07 | $1.13M derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $416.00K 10-Q · filed 2017-08-08 | $1.03M derived: sum of 3 quarters · filed 2018-03-08 | $1.74M derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | $505.00K 10-Q · filed 2017-05-09 | $1.12M derived: sum of 2 quarters · filed 2018-03-08 | $1.83M derived: sum of 3 quarters · filed 2018-03-08 | $1.82M derived: sum of 4 quarters · filed 2018-03-08 | |
| 2015-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.33M derived: sum of 2 quarters · filed 2018-03-08 | $1.32M derived: sum of 3 quarters · filed 2018-03-08 | $2.61M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $715.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $706.00K derived: sum of 2 quarters · filed 2016-11-09 | $2.00M 10-Q · filed 2016-11-09 | $2.25M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.28M 10-Q · filed 2016-08-09 | $1.53M derived: sum of 3 quarters · filed 2017-03-03 | $2.48M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-03-31 | $1.29M 10-Q · filed 2016-05-09 | $1.54M derived: sum of 2 quarters · filed 2017-03-03 | $2.48M derived: sum of 3 quarters · filed 2017-03-03 | $3.54M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2014-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $1.19M derived: sum of 2 quarters · filed 2017-03-03 | $2.24M derived: sum of 3 quarters · filed 2017-03-03 | $3.19M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $943.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.00M derived: sum of 2 quarters · filed 2015-11-09 | $2.94M 10-Q · filed 2015-11-09 | $2.93M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.00M 10-Q · filed 2015-08-10 | $1.99M derived: sum of 3 quarters · filed 2016-02-29 | $2.76M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $949.00K 10-Q · filed 2015-05-11 | -$1.42M 10-Q · filed 2014-05-12 | $937.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.71M derived: sum of 3 quarters · filed 2016-02-29 | $3.46M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $758.00K derived: sum of 2 quarters · filed 2016-02-29 | $2.51M derived: sum of 3 quarters · filed 2016-02-29 | $1.64M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $770.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $2.52M derived: sum of 2 quarters · filed 2014-11-06 | $1.65M 10-Q · filed 2014-11-06 | $1.60M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $882.00K 10-Q · filed 2014-08-04 | $829.00K derived: sum of 3 quarters · filed 2015-02-26 | $1.33M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | -$866.00K 10-Q · filed 2014-05-12 | $319.00K 10-Q · filed 2013-05-09 | -$919.00K derived: sum of 2 quarters · filed 2015-02-26 | -$415.00K derived: sum of 3 quarters · filed 2015-02-26 | $48.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $451.00K derived: sum of 2 quarters · filed 2015-02-26 | $914.00K derived: sum of 3 quarters · filed 2015-02-26 | $449.00K 10-K · filed 2015-02-26 | |
| 2012-09-30 | $504.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $967.00K derived: sum of 2 quarters · filed 2013-11-07 | $502.00K 10-Q · filed 2013-11-07 | $892.00K derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-06-30 | $463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$2.00K 10-Q · filed 2013-08-07 | $388.00K derived: sum of 3 quarters · filed 2014-03-12 | $314.00K derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-03-31 | -$465.00K 10-Q · filed 2013-05-09 | -$75.00K derived: sum of 2 quarters · filed 2014-03-12 | -$149.00K derived: sum of 3 quarters · filed 2014-03-12 | -$84.00K derived: sum of 4 quarters · filed 2014-03-12 | |
| 2011-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $316.00K derived: sum of 2 quarters · filed 2014-03-12 | $381.00K derived: sum of 3 quarters · filed 2014-03-12 | $916.00K 10-K · filed 2014-03-12 | |
| 2011-09-30 | -$74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$9.00K derived: sum of 2 quarters · filed 2012-11-09 | $526.00K 10-Q · filed 2012-11-09 | $345.00K derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $600.00K 10-Q · filed 2012-08-14 | $419.00K derived: sum of 3 quarters · filed 2013-03-12 | $512.00K derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-03-31 | $535.00K 10-Q · filed 2012-05-15 | $354.00K derived: sum of 2 quarters · filed 2013-03-12 | $447.00K derived: sum of 3 quarters · filed 2013-03-12 | ||
| 2010-12-31 | -$181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$88.00K derived: sum of 2 quarters · filed 2013-03-12 | $746.00K 10-K · filed 2013-03-12 | ||
| 2010-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $927.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $834.00K 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | -$707.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |